Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Howard

Showing results (411-420 of 429) with videos related to

Pageof 43
Sort By:
Infection and Immunity|July 15, 2015
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsRaul Herrera, Charles Anderson, Krishan Kumar, et al.
Advanced Therapeutics|October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating NeuropathiesJohn W Rumsey, Case Lorance, Max Jackson, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Neurology|June 17, 2016
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravisMamatha Pasnoor, Jianghua He, Laura Herbelin, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Pain|July 24, 2019
Pharmacological interventions for chronic pain in children: an overview of systematic reviewsChristopher Eccleston, Emma Fisher, Tess E Cooper, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Lancet (London, England)|April 24, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trialTuan Vu, Ali A Habib, Saiju Jacob, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
Pageof 43

Showing results (411-420 of 429) with videos related to

Sort By:
Pageof 43
Infection and Immunity|July 15, 2015
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsRaul Herrera, Charles Anderson, Krishan Kumar, et al.
Advanced Therapeutics|October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating NeuropathiesJohn W Rumsey, Case Lorance, Max Jackson, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
Neurology|June 17, 2016
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravisMamatha Pasnoor, Jianghua He, Laura Herbelin, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Pain|July 24, 2019
Pharmacological interventions for chronic pain in children: an overview of systematic reviewsChristopher Eccleston, Emma Fisher, Tess E Cooper, et al.
Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Lancet (London, England)|April 24, 2026
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trialTuan Vu, Ali A Habib, Saiju Jacob, et al.
Nature Medicine|January 9, 2026
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialTuan Vu, Hacer Durmus, Michael Rivner, et al.
Pageof 43